nodes	percent_of_prediction	percent_of_DWPC	metapath
Thalidomide—TNF—osteoarthritis	0.572	0.678	CbGaD
Thalidomide—PTGS2—osteoarthritis	0.272	0.322	CbGaD
Thalidomide—Lenalidomide—TNFSF11—osteoarthritis	0.00769	0.61	CrCbGaD
Thalidomide—Menadione—BGLAP—osteoarthritis	0.00202	0.16	CrCbGaD
Thalidomide—Pomalidomide—TNF—osteoarthritis	0.00146	0.116	CrCbGaD
Thalidomide—Lenalidomide—PTGS2—osteoarthritis	0.000747	0.0592	CrCbGaD
Thalidomide—Pomalidomide—PTGS2—osteoarthritis	0.000695	0.0551	CrCbGaD
Thalidomide—TNF—Transcriptional regulation of white adipocyte differentiation—TGFB1—osteoarthritis	0.000128	0.000898	CbGpPWpGaD
Thalidomide—NFKB1—DNA Damage Response (only ATM dependent)—TGFB1—osteoarthritis	0.000128	0.000892	CbGpPWpGaD
Thalidomide—TNF—Spinal Cord Injury—PTGS2—osteoarthritis	0.000126	0.000883	CbGpPWpGaD
Thalidomide—TNF—Allograft Rejection—TGFB1—osteoarthritis	0.000126	0.00088	CbGpPWpGaD
Thalidomide—NFKB1—Toll-like Receptor Signaling Pathway—TNF—osteoarthritis	0.000126	0.000879	CbGpPWpGaD
Thalidomide—PTGS1—Selenium Micronutrient Network—PTGS2—osteoarthritis	0.000124	0.000869	CbGpPWpGaD
Thalidomide—NFKB1—Myometrial Relaxation and Contraction Pathways—IL1B—osteoarthritis	0.000124	0.000867	CbGpPWpGaD
Thalidomide—NFKB1—SIDS Susceptibility Pathways—IL1B—osteoarthritis	0.000123	0.000862	CbGpPWpGaD
Thalidomide—TNF—Spinal Cord Injury—CXCL8—osteoarthritis	0.000122	0.000856	CbGpPWpGaD
Thalidomide—NFKB1—Glucocorticoid receptor regulatory network—IL6—osteoarthritis	0.000121	0.000844	CbGpPWpGaD
Thalidomide—TNF—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—osteoarthritis	0.00012	0.000837	CbGpPWpGaD
Thalidomide—TNF—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.00012	0.000837	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by SCF-KIT—MMP9—osteoarthritis	0.00012	0.000836	CbGpPWpGaD
Thalidomide—TNF—Spinal Cord Injury—IL1B—osteoarthritis	0.000117	0.000821	CbGpPWpGaD
Thalidomide—CYP1A2—Biological oxidations—GSTO1—osteoarthritis	0.000117	0.000821	CbGpPWpGaD
Thalidomide—NFKB1—MyD88 cascade initiated on plasma membrane—IL6—osteoarthritis	0.000117	0.00082	CbGpPWpGaD
Thalidomide—NFKB1—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—osteoarthritis	0.000116	0.000813	CbGpPWpGaD
Thalidomide—NFKB1—MAPK Signaling Pathway—IL1B—osteoarthritis	0.000116	0.000812	CbGpPWpGaD
Thalidomide—CYP1A2—Metapathway biotransformation—GSTO1—osteoarthritis	0.000116	0.000809	CbGpPWpGaD
Thalidomide—PTGS1—Selenium Micronutrient Network—IL1B—osteoarthritis	0.000116	0.000809	CbGpPWpGaD
Thalidomide—NFKB1—Selenium Micronutrient Network—IL6—osteoarthritis	0.000114	0.000798	CbGpPWpGaD
Thalidomide—NFKB1—MyD88 dependent cascade initiated on endosome—IL6—osteoarthritis	0.000114	0.000798	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—LEP—osteoarthritis	0.000114	0.000797	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—HSPA5—osteoarthritis	0.000114	0.000796	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000113	0.00079	CbGpPWpGaD
Thalidomide—NFKB1—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.000113	0.000788	CbGpPWpGaD
Thalidomide—CYP2C19—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.000113	0.000788	CbGpPWpGaD
Thalidomide—NFKB1—TCR Signaling Pathway—IL6—osteoarthritis	0.000112	0.000784	CbGpPWpGaD
Thalidomide—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	0.000112	0.000783	CbGpPWpGaD
Thalidomide—NFKB1—Cellular Senescence—CXCL8—osteoarthritis	0.000112	0.000781	CbGpPWpGaD
Thalidomide—FGFR2—IRS-mediated signalling—IL6—osteoarthritis	0.000111	0.000779	CbGpPWpGaD
Thalidomide—TNF—Spinal Cord Injury—MMP9—osteoarthritis	0.000111	0.000774	CbGpPWpGaD
Thalidomide—NFKB1—Toll Like Receptor 9 (TLR9) Cascade—IL6—osteoarthritis	0.00011	0.00077	CbGpPWpGaD
Thalidomide—NFKB1—TNF alpha Signaling Pathway—IL6—osteoarthritis	0.00011	0.00077	CbGpPWpGaD
Thalidomide—TNF—Folate Metabolism—IL6—osteoarthritis	0.000109	0.000765	CbGpPWpGaD
Thalidomide—FGFR2—IRS-related events—IL6—osteoarthritis	0.000108	0.000757	CbGpPWpGaD
Thalidomide—NFKB1—MyD88:Mal cascade initiated on plasma membrane—IL6—osteoarthritis	0.000108	0.000757	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—HSPA5—osteoarthritis	0.000108	0.000755	CbGpPWpGaD
Thalidomide—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—osteoarthritis	0.000107	0.000751	CbGpPWpGaD
Thalidomide—FGFR2—IRS-related events triggered by IGF1R—IL6—osteoarthritis	0.000107	0.00075	CbGpPWpGaD
Thalidomide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoarthritis	0.000106	0.000744	CbGpPWpGaD
Thalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoarthritis	0.000105	0.000732	CbGpPWpGaD
Thalidomide—FGFR2—Insulin receptor signalling cascade—IL6—osteoarthritis	0.000104	0.000731	CbGpPWpGaD
Thalidomide—FGFR2—IGF1R signaling cascade—IL6—osteoarthritis	0.000104	0.000731	CbGpPWpGaD
Thalidomide—NFKB1—MyD88-independent cascade—IL6—osteoarthritis	0.000104	0.000726	CbGpPWpGaD
Thalidomide—TNF—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.000104	0.000724	CbGpPWpGaD
Thalidomide—TNF—Regulation of toll-like receptor signaling pathway—IL1B—osteoarthritis	0.000103	0.00072	CbGpPWpGaD
Thalidomide—CYP2C9—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.000103	0.000718	CbGpPWpGaD
Thalidomide—NFKB1—Toll-like Receptor Signaling Pathway—IL6—osteoarthritis	0.000101	0.000709	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.0001	0.000701	CbGpPWpGaD
Thalidomide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—osteoarthritis	9.94e-05	0.000695	CbGpPWpGaD
Thalidomide—CYP1A1—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	9.94e-05	0.000695	CbGpPWpGaD
Thalidomide—NFKB1—Senescence-Associated Secretory Phenotype (SASP)—IL6—osteoarthritis	9.91e-05	0.000693	CbGpPWpGaD
Thalidomide—FGFR2—Disease—TGFBI—osteoarthritis	9.86e-05	0.00069	CbGpPWpGaD
Thalidomide—NFKB1—Regulation of toll-like receptor signaling pathway—TNF—osteoarthritis	9.81e-05	0.000686	CbGpPWpGaD
Thalidomide—TNF—SIDS Susceptibility Pathways—CXCL8—osteoarthritis	9.79e-05	0.000685	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—MCF2L—osteoarthritis	9.76e-05	0.000683	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—IHH—osteoarthritis	9.76e-05	0.000683	CbGpPWpGaD
Thalidomide—NFKB1—Signaling by Interleukins—IL6—osteoarthritis	9.69e-05	0.000677	CbGpPWpGaD
Thalidomide—TNF—SIDS Susceptibility Pathways—IL1B—osteoarthritis	9.39e-05	0.000657	CbGpPWpGaD
Thalidomide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—osteoarthritis	9.38e-05	0.000656	CbGpPWpGaD
Thalidomide—NFKB1—Activated TLR4 signalling—IL6—osteoarthritis	9.34e-05	0.000653	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—MCF2L—osteoarthritis	9.27e-05	0.000648	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—IHH—osteoarthritis	9.27e-05	0.000648	CbGpPWpGaD
Thalidomide—PTGS2—Selenium Micronutrient Network—IL1B—osteoarthritis	9.18e-05	0.000642	CbGpPWpGaD
Thalidomide—TNF—Spinal Cord Injury—TGFB1—osteoarthritis	9.12e-05	0.000638	CbGpPWpGaD
Thalidomide—NFKB1—MAPK Signaling Pathway—TGFB1—osteoarthritis	9.03e-05	0.000631	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—SMAD3—osteoarthritis	9e-05	0.000629	CbGpPWpGaD
Thalidomide—NFKB1—SIDS Susceptibility Pathways—TNF—osteoarthritis	8.94e-05	0.000626	CbGpPWpGaD
Thalidomide—TNF—MAPK Signaling Pathway—IL1B—osteoarthritis	8.85e-05	0.000619	CbGpPWpGaD
Thalidomide—NFKB1—Toll Like Receptor 4 (TLR4) Cascade—IL6—osteoarthritis	8.79e-05	0.000615	CbGpPWpGaD
Thalidomide—CYP1A2—Arachidonic acid metabolism—PTGS2—osteoarthritis	8.78e-05	0.000614	CbGpPWpGaD
Thalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoarthritis	8.73e-05	0.000611	CbGpPWpGaD
Thalidomide—TNF—Selenium Micronutrient Network—IL6—osteoarthritis	8.69e-05	0.000608	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by Insulin receptor—IL6—osteoarthritis	8.68e-05	0.000607	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CAMK2B—osteoarthritis	8.67e-05	0.000607	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CTSK—osteoarthritis	8.67e-05	0.000607	CbGpPWpGaD
Thalidomide—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	8.58e-05	0.0006	CbGpPWpGaD
Thalidomide—FGFR2—Disease—GSTO1—osteoarthritis	8.53e-05	0.000596	CbGpPWpGaD
Thalidomide—TNF—Adipogenesis—TGFB1—osteoarthritis	8.44e-05	0.000591	CbGpPWpGaD
Thalidomide—NFKB1—Cellular responses to stress—CXCL8—osteoarthritis	8.43e-05	0.00059	CbGpPWpGaD
Thalidomide—NFKB1—MAPK Signaling Pathway—TNF—osteoarthritis	8.43e-05	0.00059	CbGpPWpGaD
Thalidomide—PTGS1—Selenium Micronutrient Network—TNF—osteoarthritis	8.39e-05	0.000587	CbGpPWpGaD
Thalidomide—TNF—TNF alpha Signaling Pathway—IL6—osteoarthritis	8.39e-05	0.000587	CbGpPWpGaD
Thalidomide—FGFR2—Disease—BGN—osteoarthritis	8.26e-05	0.000578	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CAMK2B—osteoarthritis	8.23e-05	0.000576	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CTSK—osteoarthritis	8.23e-05	0.000576	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	8.21e-05	0.000574	CbGpPWpGaD
Thalidomide—NFKB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	8.15e-05	0.00057	CbGpPWpGaD
Thalidomide—NFKB1—Regulation of toll-like receptor signaling pathway—IL6—osteoarthritis	7.92e-05	0.000554	CbGpPWpGaD
Thalidomide—NFKB1—Toll-Like Receptors Cascades—IL6—osteoarthritis	7.83e-05	0.000547	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—FMOD—osteoarthritis	7.78e-05	0.000544	CbGpPWpGaD
Thalidomide—TNF—Toll-like Receptor Signaling Pathway—IL6—osteoarthritis	7.72e-05	0.00054	CbGpPWpGaD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—IL1B—osteoarthritis	7.72e-05	0.00054	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—LEP—osteoarthritis	7.69e-05	0.000538	CbGpPWpGaD
Thalidomide—NFKB1—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	7.61e-05	0.000532	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—CXCL8—osteoarthritis	7.57e-05	0.000529	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	7.48e-05	0.000523	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by SCF-KIT—IL6—osteoarthritis	7.42e-05	0.000519	CbGpPWpGaD
Thalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	7.4e-05	0.000517	CbGpPWpGaD
Thalidomide—PTGS2—Disease—FMOD—osteoarthritis	7.37e-05	0.000516	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—IL1B—osteoarthritis	7.26e-05	0.000508	CbGpPWpGaD
Thalidomide—NFKB1—Myometrial Relaxation and Contraction Pathways—IL6—osteoarthritis	7.25e-05	0.000507	CbGpPWpGaD
Thalidomide—NFKB1—SIDS Susceptibility Pathways—IL6—osteoarthritis	7.22e-05	0.000505	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—COL9A2—osteoarthritis	7.17e-05	0.000501	CbGpPWpGaD
Thalidomide—FGFR2—Downstream signaling of activated FGFR—IL6—osteoarthritis	7.1e-05	0.000497	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by ERBB4—IL6—osteoarthritis	6.99e-05	0.000489	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—COL9A1—osteoarthritis	6.96e-05	0.000487	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—CRP—osteoarthritis	6.94e-05	0.000485	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—HSPA5—osteoarthritis	6.9e-05	0.000483	CbGpPWpGaD
Thalidomide—TNF—MAPK Signaling Pathway—TGFB1—osteoarthritis	6.88e-05	0.000481	CbGpPWpGaD
Thalidomide—TNF—Spinal Cord Injury—IL6—osteoarthritis	6.87e-05	0.000481	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—SMAD3—osteoarthritis	6.85e-05	0.000479	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—MMP9—osteoarthritis	6.85e-05	0.000479	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—COL9A2—osteoarthritis	6.8e-05	0.000476	CbGpPWpGaD
Thalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoarthritis	6.78e-05	0.000474	CbGpPWpGaD
Thalidomide—PTGS1—Selenium Micronutrient Network—IL6—osteoarthritis	6.77e-05	0.000474	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IL1RN—osteoarthritis	6.72e-05	0.00047	CbGpPWpGaD
Thalidomide—FGFR2—Downstream signal transduction—IL6—osteoarthritis	6.68e-05	0.000467	CbGpPWpGaD
Thalidomide—PTGS2—Selenium Micronutrient Network—TNF—osteoarthritis	6.66e-05	0.000466	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by FGFR—IL6—osteoarthritis	6.64e-05	0.000465	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by ERBB2—IL6—osteoarthritis	6.61e-05	0.000462	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—COL9A1—osteoarthritis	6.6e-05	0.000462	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—CRP—osteoarthritis	6.58e-05	0.00046	CbGpPWpGaD
Thalidomide—FGFR2—DAP12 signaling—IL6—osteoarthritis	6.58e-05	0.00046	CbGpPWpGaD
Thalidomide—PTGS2—Disease—IHH—osteoarthritis	6.57e-05	0.00046	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—HSPA5—osteoarthritis	6.55e-05	0.000458	CbGpPWpGaD
Thalidomide—NFKB1—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	6.52e-05	0.000456	CbGpPWpGaD
Thalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	6.4e-05	0.000448	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	6.4e-05	0.000447	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IL1RN—osteoarthritis	6.37e-05	0.000446	CbGpPWpGaD
Thalidomide—TNF—Adipogenesis—IL6—osteoarthritis	6.36e-05	0.000445	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—PTGES—osteoarthritis	6.34e-05	0.000443	CbGpPWpGaD
Thalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoarthritis	6.33e-05	0.000443	CbGpPWpGaD
Thalidomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	6.33e-05	0.000443	CbGpPWpGaD
Thalidomide—NFKB1—Cellular Senescence—IL6—osteoarthritis	6.27e-05	0.000439	CbGpPWpGaD
Thalidomide—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	6.21e-05	0.000434	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by FGFR in disease—IL6—osteoarthritis	6.19e-05	0.000433	CbGpPWpGaD
Thalidomide—FGFR2—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	6.19e-05	0.000433	CbGpPWpGaD
Thalidomide—FGFR2—DAP12 interactions—IL6—osteoarthritis	6.19e-05	0.000433	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—FMOD—osteoarthritis	6.17e-05	0.000432	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—MMP2—osteoarthritis	6.15e-05	0.00043	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by EGFR—IL6—osteoarthritis	6.13e-05	0.000429	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by EGFR in Cancer—IL6—osteoarthritis	6.08e-05	0.000425	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by PDGF—IL6—osteoarthritis	6.05e-05	0.000423	CbGpPWpGaD
Thalidomide—TNF—Regulation of toll-like receptor signaling pathway—IL6—osteoarthritis	6.03e-05	0.000422	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—LEP—osteoarthritis	5.86e-05	0.00041	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—FMOD—osteoarthritis	5.81e-05	0.000406	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—FMOD—osteoarthritis	5.8e-05	0.000406	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—TGFB1—osteoarthritis	5.64e-05	0.000395	CbGpPWpGaD
Thalidomide—TNF—SIDS Susceptibility Pathways—IL6—osteoarthritis	5.5e-05	0.000385	CbGpPWpGaD
Thalidomide—FGFR2—NGF signalling via TRKA from the plasma membrane—IL6—osteoarthritis	5.48e-05	0.000383	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—FMOD—osteoarthritis	5.48e-05	0.000383	CbGpPWpGaD
Thalidomide—PTGS2—Selenium Micronutrient Network—IL6—osteoarthritis	5.38e-05	0.000376	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—TNF—osteoarthritis	5.27e-05	0.000369	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—PTGES—osteoarthritis	5.03e-05	0.000352	CbGpPWpGaD
Thalidomide—PTGS2—Disease—TGFBI—osteoarthritis	4.9e-05	0.000343	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IL1A—osteoarthritis	4.83e-05	0.000338	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—BMP2—osteoarthritis	4.77e-05	0.000334	CbGpPWpGaD
Thalidomide—NFKB1—Cellular responses to stress—IL6—osteoarthritis	4.74e-05	0.000331	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—PTGES—osteoarthritis	4.74e-05	0.000331	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—PTGES—osteoarthritis	4.73e-05	0.000331	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—MMP2—osteoarthritis	4.68e-05	0.000328	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—MMP9—osteoarthritis	4.62e-05	0.000323	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IL1A—osteoarthritis	4.59e-05	0.000321	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—BMP2—osteoarthritis	4.52e-05	0.000316	CbGpPWpGaD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—IL6—osteoarthritis	4.52e-05	0.000316	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—FMOD—osteoarthritis	4.48e-05	0.000314	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—GSTO1—osteoarthritis	4.47e-05	0.000312	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—PTGES—osteoarthritis	4.47e-05	0.000312	CbGpPWpGaD
Thalidomide—NFKB1—Signaling by NGF—IL6—osteoarthritis	4.44e-05	0.000311	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—BGN—osteoarthritis	4.33e-05	0.000303	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—IL6—osteoarthritis	4.25e-05	0.000297	CbGpPWpGaD
Thalidomide—PTGS2—Disease—GSTO1—osteoarthritis	4.23e-05	0.000296	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by NGF—IL6—osteoarthritis	4.22e-05	0.000295	CbGpPWpGaD
Thalidomide—PTGS2—Disease—BGN—osteoarthritis	4.1e-05	0.000287	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—FMOD—osteoarthritis	4.09e-05	0.000286	CbGpPWpGaD
Thalidomide—FGFR2—Disease—SMAD3—osteoarthritis	4.05e-05	0.000283	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CRP—osteoarthritis	4.04e-05	0.000283	CbGpPWpGaD
Thalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	3.84e-05	0.000268	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CRP—osteoarthritis	3.83e-05	0.000268	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—TGFB1—osteoarthritis	3.81e-05	0.000266	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—PTGES—osteoarthritis	3.66e-05	0.000256	CbGpPWpGaD
Thalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	3.58e-05	0.000251	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—TNF—osteoarthritis	3.56e-05	0.000249	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—GSTO1—osteoarthritis	3.55e-05	0.000248	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—MMP9—osteoarthritis	3.52e-05	0.000246	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—FMOD—osteoarthritis	3.49e-05	0.000244	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—BGN—osteoarthritis	3.43e-05	0.00024	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—GSTO1—osteoarthritis	3.34e-05	0.000233	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—PTGES—osteoarthritis	3.33e-05	0.000233	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—GSTO1—osteoarthritis	3.33e-05	0.000233	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—MMP3—osteoarthritis	3.31e-05	0.000231	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—BGN—osteoarthritis	3.23e-05	0.000226	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—BGN—osteoarthritis	3.23e-05	0.000226	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—GSTO1—osteoarthritis	3.15e-05	0.00022	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—MMP3—osteoarthritis	3.14e-05	0.000219	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—BGN—osteoarthritis	3.05e-05	0.000213	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—SMAD3—osteoarthritis	2.99e-05	0.000209	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—TGFB1—osteoarthritis	2.9e-05	0.000203	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—IL6—osteoarthritis	2.87e-05	0.000201	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—PTGES—osteoarthritis	2.85e-05	0.000199	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—SMAD3—osteoarthritis	2.84e-05	0.000199	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	2.79e-05	0.000195	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—GSTO1—osteoarthritis	2.58e-05	0.00018	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—LEP—osteoarthritis	2.56e-05	0.000179	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—IL6—osteoarthritis	2.53e-05	0.000177	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IL1B—osteoarthritis	2.52e-05	0.000176	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—BGN—osteoarthritis	2.49e-05	0.000174	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—ESR1—osteoarthritis	2.44e-05	0.000171	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—LEP—osteoarthritis	2.43e-05	0.00017	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—FN1—osteoarthritis	2.41e-05	0.000169	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—IL6—osteoarthritis	2.41e-05	0.000168	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IL1B—osteoarthritis	2.39e-05	0.000167	CbGpPWpGaD
Thalidomide—FGFR2—Disease—PTGS2—osteoarthritis	2.37e-05	0.000166	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—GSTO1—osteoarthritis	2.35e-05	0.000164	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—ESR1—osteoarthritis	2.32e-05	0.000162	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—FN1—osteoarthritis	2.29e-05	0.00016	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—BGN—osteoarthritis	2.27e-05	0.000159	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—IL6—osteoarthritis	2.19e-05	0.000153	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—IGF1—osteoarthritis	2.11e-05	0.000148	CbGpPWpGaD
Thalidomide—PTGS2—Disease—SMAD3—osteoarthritis	2.01e-05	0.000141	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—GSTO1—osteoarthritis	2.01e-05	0.00014	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—IGF1—osteoarthritis	2e-05	0.00014	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	1.97e-05	0.000138	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—BGN—osteoarthritis	1.94e-05	0.000136	CbGpPWpGaD
Thalidomide—FGFR2—Disease—TGFB1—osteoarthritis	1.72e-05	0.00012	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CXCL8—osteoarthritis	1.7e-05	0.000119	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CXCL8—osteoarthritis	1.61e-05	0.000113	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	1.61e-05	0.000113	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—MMP9—osteoarthritis	1.54e-05	0.000107	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IL6—osteoarthritis	1.48e-05	0.000103	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	1.47e-05	0.000103	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—MMP9—osteoarthritis	1.46e-05	0.000102	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IL6—osteoarthritis	1.4e-05	9.8e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—IL6—osteoarthritis	1.29e-05	9.05e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—TGFB1—osteoarthritis	1.27e-05	8.86e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	1.25e-05	8.77e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—PTGS2—osteoarthritis	1.24e-05	8.7e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—TGFB1—osteoarthritis	1.2e-05	8.41e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—IL6—osteoarthritis	9.55e-06	6.68e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—PTGS2—osteoarthritis	9.29e-06	6.5e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—PTGS2—osteoarthritis	9.27e-06	6.49e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—IL6—osteoarthritis	9.06e-06	6.33e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—PTGS2—osteoarthritis	8.76e-06	6.13e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—TGFB1—osteoarthritis	8.52e-06	5.96e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—PTGS2—osteoarthritis	7.17e-06	5.02e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—PTGS2—osteoarthritis	6.54e-06	4.57e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—IL6—osteoarthritis	6.42e-06	4.49e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—PTGS2—osteoarthritis	5.59e-06	3.91e-05	CbGpPWpGaD
